Osteoarthritis Trial, Recruiting NCT07329023 Sponsor: The Hong Kong Polytechnic University Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07329023
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are of Chinese ethnicity
  • People aged 60 years or older
  • People who are able to read Chinese and understand Mandarin or Cantonese
  • People who have at least 3 of the following knee symptoms: morning stiffness lasting 30 minutes or more; a clicking or cracking sound when moving the knee joint; tenderness in the bones around the knee; visible or felt bone enlargement around the knee; or no noticeable warmth in the knee joint when touched
  • People who have had knee pain for at least 3 months
  • People whose knee pain rates at 3 or higher on a pain scale of 1 to 10
  • People who have access to a smartphone that supports WhatsApp, either their own or belonging to a family member living in the same household
  • People who are willing to give their formal agreement to take part in the trial

Who may not be able to join:

  • People who have certain medical conditions that would prevent active physical participation, such as bleeding disorders or substance misuse issues
  • People whose knee pain appears to be caused by something other than osteoarthritis, such as cancer, a bone fracture, rheumatoid arthritis, or rheumatism, as determined using established medical guidelines
  • People who score below 22 on a standardised cognitive assessment (the Hong Kong Montreal Cognitive Assessment), which may indicate difficulty understanding the study instructions
  • People with a body mass index (a measure of body weight relative to height) above 30, which is the threshold for obesity used in guidelines for Asian populations
  • People who have previously had knee replacement surgery on either knee

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: WIng-Fai YEUNG, Phd, School of Nursing. the Hong Kong Polytechnic University, Hong Kong

Phone: 27664151

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Hong Kong Polytechnic University
Registry
ClinicalTrials.gov
Start date
20 December 2025
Est. completion
30 November 2027

Where this trial is recruiting

Hong Kong

Primary endpoints

Numerical rating scale (NRS) for pain severity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov